Thyroid hormone indices during illness in six hypothyroid subjects rendered euthyroid with levothyroxine therapy

Experimental and Clinical Endocrinology and Diabetes

Volumn 112, Issue 7, 2004, Pages 373-377

  Wadwekar, D ^a   Kabadi, Udaya M ^b,c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b CARL T HAYDEN VA MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Euthyroid sick syndrome; Hypothyroid; Non thyroidal illness syndrome; Thyroid hormone indices; Thyroxine replacement

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EUTHYROID SICK SYNDROME; FOLLOW UP; HORMONE BLOOD LEVEL; HOSPITALIZATION; HUMAN; HYPOTHYROIDISM; LINEAR REGRESSION ANALYSIS; MALE; PRIORITY JOURNAL; SUBSTITUTION THERAPY; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE METABOLISM; THYROID HORMONE RELEASE;

ACUTE DISEASE; AGED; HOSPITALIZATION; HUMANS; HYPOTHYROIDISM; INTENSIVE CARE; MALE; MIDDLE AGED; THYROID HORMONES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE; TRIIODOTHYRONINE, REVERSE;

EID: 3142684120     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-821012     Document Type: Article

References (50)

1. Adriaanse R, Romijn JA, Brabant G, Endert E, Wiersinga WM. Pulsatile thyrotropin secretion in nonthyroidal illness. J Clin Endocrinol Metab 1993; 77: 1313-1317
2. Afandi B, Schussler GC, Arafeh AH, Boutros A, Yap MG, Finkelstein A. Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. Metabolism 2000; 49: 270-274
3. Bacci V, Schussler GC, Kaplan TB. The relationship between serum triiodothyronine and thyrotropin during systemic illness. J Clin Endocrinol Metab 1982; 54: 1229-1235
4. Berry MJ, Banu L, Larsen PR. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 1991; 349: 438-440
5. Bianchi R, Mariani G, Molea N, Vitek F, Cazzuola F, Carpi A, Mazzuca N, Toni MG. Peripheral metabolism of thyroid hormones in man. I. Direct measurement of the conversion rate of thyroxine to 3,5,3′-triiodothyronine (T3) and determination of the peripheral and thyroidal production of T3. J Clin Endocrinol Metab 1983; 56: 1152-1163
6. Bianco AC, Nunes MT, Hell NS, Maciel RM. The role of glucocorticoids in the stress-induced reduction of extrathyroidal 3,5,3′-triiodothyronine generation in rats. Endocrinology 1987; 120: 1033-1038
7. Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM. Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J Endocrinol 1997; 153: 115-122
8. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63: 1-8
9. Brent GA, Hershman JM, Braunstein GD. Patients with severe nonthyroidal illness and serum thyrotropin concentrations in the hypothyroid range. Am J Med 1986; 81: 463-466
10. Chopra IJ, Chopra U, Smith SR, Reza M, Solomon DH. Reciprocal changes in serum concentrations of 3,3′,5-triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Metab 1975; 41: 1043-1049
11. Chopra IJ, Huang TS, Beredo A, Solomon DH, Chua Teco GN, Mead JF. Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab 1985; 60: 666-672
12. Chopra IJ, Huang TS, Solomon DH, Chaudhuri G, Teco GN. The role of thyroxine (T4)-binding serum proteins in oleic acid-induced increase in free T4 in nonthyroidal illnesses. J Clin Endocrinol Metab 1986; 63: 776-779
13. Chopra IJ, Smith SR. Circulating thyroid hormones and thyrotropin in adult patients with protein-calorie malnutrition. J Clin Endocrinol Metab 1975; 40: 221-227
14. Chopra IJ, Teco GN, Nguyen AH, Solomon DH. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses. J Clin Endocrinol Metab 1979; 49: 63-69
15. Davis FB, Spector DA, Davis PJ, Hirsch BR, Walshe JJ, Yoshida K. Comparison of pituitary-thyroid function in patients with end stage renal disease and in age- and sex-matched controls. Kid Inter 1982; 21: 362-364
16. Duntas LH, Nguyen TT, Keck FS, Nelson DK, Iii JJ. Changes in metabolism of TRH in euthyroid sick syndrome. Euro J Endocrinol 1999; 141: 337-341
17. Faber J, Kirkegaard C, Rasmussen B, Westh H, Busch-Sorensen M, Jensen IW. Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987; 65: 315-320
18. Feelders RA, Swaak AJ, Romijn JA, Eggermont AM, Tielens ET, Vreugdenhil G, Endert E, van Eijk HG, Berghout A. Characteristics of recovery from the euthyroid sick syndrome induced by tumor necrosis factor alpha in cancer patients. Metabolism 1999; 48: 324-329
19. Hamblin PS, Dyer SA, Mohr VS, Le Grand BA, Lim CF, Tuxen DV, Topliss DJ, Stockigt JR. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J Clin Endocrinol Metab 1986; 62: 717-722
20. Hidal JT, Kaplan MM. Inhibition of thyroxine 5′-deiodination type II in cultured human placental cells by cortisol, insulin, 3′, 5′-cyclic adenosine monophosphate, and butyrate. Metabolism 1988; 37: 664-668
21. Jennings AS, Ferguson DC, Utiger RD. Regulation of the conversion of thyroxine to triiodothyronine in the perfused rat liver. J Clin Invest 1979; 64: 1614-1623
22. Kabadi U, Fragstedt L 2nd. Impaired TSH secretion during sustained hyperglucagonemia in anesthetized dogs. Thyroid 1995; 5: 389-393
23. Kabadi UM. Impaired pituitary thyrotroph function in uncontrolled type II diabetes mellitus: normalization on recovery. J Clin Endocrinol Metab 1984; 59: 521-525
24. Kabadi UM. Thyrotropin dysregulation during a non-thyroidal illness: transient hypothalamic hypothyroidism? J Endocrinol Invest 2001; 24: 178-182
25. Kabadi UM, Kabadi MU. Serum Thyrotropin in primary hypothyroidism: a reliable and accurate predictor of optimal daily levothyroxine dose. Endocr Pract 2001; 7: 16-18
26. Kabadi UM, Kabadi MU, Premachandra BN. Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon. Am J Gastroenterol 1991; 86: 1504-1507
27. Kabadi UM, Premachandra BN. Low triiodothyronine and raised reverse triiodothyronine levels in patients over fifty years of age who have type II diabetes mellitus: influence of metabolic control, not age. J Am Ger Soc 1984; 32: 375-379
28. Kabadi UM, Premachandra BN. Glucagon administration induces lowering of serum T3 and rise in reverse T3 in euthyroid healthy subjects. Horm Metab Res 1985; 17: 667-670
29. Kabadi UM, Premachandra BN. Lowering of T3 and rise in reverse T3 induced by hyperglucagonemia: altered thyroid hormone metabolism, not altered release of thyroid hormones. Horm Metab Res 1987; 19: 486-489
30. Kabadi UM, Premachandra BN. Decline of T3 and elevation in reverse T3 induced by hyperglucagonemia: changes in thyroid hormone metabolism, not altered release of thyroid hormones. Horm Metab Res 1988; 20: 513-516
31. Kabadi UM, Premachandra BN, Maayan M. Low serum 3,5,3′- triiodothyronine (T3) and raised 3,3′,5′-triidothyronine (reverse T3 or RT3) in diabetes mellitus: normalization on improvement in hyperglycemia. Acta Diab Lat 1982; 19: 233-242
32. Kayima JK, Otieno LS, Gitau W, Mwai S. Thyroid hormone profiles in patients with chronic renal failure on conservative management and regular haemodialysis. E Afr Med J 1992; 69: 333-336
33. Kimura T, Kanda T, Kotajima N, Kuwabara A, Fukumura Y, Kobayashi I. Involvement of circulating interleukin-6 and its receptor in the development of euthyroid sick syndrome in patients with acute myocardial infarction. Eur J Endocrinol 2000; 143: 179-184
34. Langer P, Balazova E, Vician M, Martino E, Jezova D, Michalikova S, Moravec R. Acute development of low T3 syndrome and changes in pituitary-adrenocortical function after elective cholecystectomy in women: some differences between young and elderly patients. Scand J Clin Lab Invest 1992; 52: 215-220
35. Langer P, Foldes O. Effect of adrenaline on biliary excretion of triiodothyronines in rats mediated by alpha 1-adrenoceptors and related to the inhibition of 5′-monodeiodination in liver. J Endocrinol Invest 1988; 11: 471-476
36. Langer P, Foldes O, Gschwendtova K. Effect of the glycogenolytic gluconeogenetic hormones, glucagon, vasopressin and angiotensin II, on biliary excretion of iodothyronines in rats is possibly related to the inhibition of 5′-monodeiodination in the liver. J Endocrinol 1989; 121: 299-302
37. Langer P, Suzuki M, Kakegawa T, Foldes O, Gschwendtova K. Acute changes of iodothyronine excretion by bile after a single and repeated administration of dexamethasone in rats. Endocrinol Exp 1985; 19: 253-260
38. Michalaki M, Vagenakis AG, Makri M, Kalfarentzos F, Kyriazopoulou V. Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. J Clin Endocrinol Metab 2001; 86: 4198-4205
39. Oppenheimer JH, Schwartz HL, Mariash CN, Kaiser FE. Evidence for a factor in the sera of patients with nonthyroidal disease which inhibits iodothyronine binding by solid matrices, serum proteins, and rat hepatocytes. J Clin Endocrinol Metab 1982; 54: 757-766
40. Pittman CS, Suda AK, Chambers JB Jr, McDaniel HG, Ray GY, Preston BK. Abnormalities of thyroid hormone turnover in patients with diabetes mellitus before and after insulin therapy. J Clin Endocrinol Metab 1979; 48: 854-860
41. Premachandra BN. A simple and rapid radioimmunoassay of triiodothyronine in unextracted serum. J Nucl Med 1976; 17: 411-416
42. Premachandra BN. Radioimmunoassay of reverse triiodothyronine. J Clin Endocrinol Metab 1978; 47: 746-750
43. Premachandra BN, Ibrahim II. A simple and rapid thyroxine radioimmunoassy (T4-RIA) in unextracted human serum; a comparison of T4-RIA and T4 displacement assay, T4(D), in normal and pathologic sera. Clinica Chimica Acta 1976; 70: 43-60
44. Ramirez G, O'Neill W Jr, Jubiz W, Bloomer HA. Thyroid dysfunction in uremia: evidence for thyroid and hypophyseal abnormalities. Ann Inter Med 1976; 84: 672-676
45. Silva JE, Dick TE, Larsen PR. The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3′-triiodothyronine in pituitary, liver, and kidney of euthyroid rats. Endocrinol 1978; 103: 1196-1207
46. Silva JE, Larsen PR. Hormonal regulation of iodothyronine 5′-deiodinase in rat brown adipose tissue. Am J Physiol 1986; 251: E639-643
47. Silva JE, Leonard JL, Crantz FR, Larsen PR. Evidence for two tissue-specific pathways for in vivo thyroxine 5′-deiodination in the rat. J Clin Invest 1982; 69: 1176-1184
48. Spencer CA, Lum SM, Wilber JF, Kaptein EM, Nicoloff JT. Dynamics of serum thyrotropin and thyroid hormone changes in fasting. J Clin Endocrinol Metab 1983; 6: 883-888
49. Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Gouwy S, Stockman W, Weekers F, Schetz M, Lauwers P, Bouillon R, Bowers CY. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues. Clin Endocrinol 1997; 47: 599-612
50. Wu SY. Thyrotropin-mediated induction of thyroidal iodothyronine monodeiodinases in the dog. Endocrinology 1983; 112: 417-424